Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Peptides and Heparin for Diabetes

Out of Stock

Price data last checked 112 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 182 days. Could come back at any time — we're watching for you.

Out of stock 182 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 536 days • 536 data points (No recent data available)

Historical
Generating forecast...
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 01 September 2024 12 January 2025 26 May 2025 07 October 2025 18 February 2026

Price Distribution

Price distribution over 536 days • 1 price levels

Days at Price
536 days 0 134 268 402 536 £790 Days at Price

Price Analysis

Most common price: £790 (536 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 536 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
28 April 2024

Similar Products You Might Like

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan
99% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in Japan

£495.00 29 Jan 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India

£515.00 07 Feb 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes for US Zip Codes

£490.00 07 Feb 2026
The 2026-2031 World Outlook for Unfractionated Heparin
97% match

The 2026-2031 World Outlook for Unfractionated Heparin

£885.00 02 Mar 2026
The 2025-2030 World Outlook for Heparin
97% match

The 2025-2030 World Outlook for Heparin

Out of Stock 13 Jan 2026
The 2025-2030 World Outlook for Heparin Anticoagulants
97% match

The 2025-2030 World Outlook for Heparin Anticoagulants

Out of Stock 13 Jan 2026
The 2025-2030 World Outlook for Unfractionated Heparin
97% match

The 2025-2030 World Outlook for Unfractionated Heparin

Out of Stock 25 Jan 2026
The 2025-2030 World Outlook for Crude Heparin
96% match

The 2025-2030 World Outlook for Crude Heparin

Out of Stock 12 Jan 2026
The 2023-2028 World Outlook for Heparin Anticoagulants
96% match

The 2023-2028 World Outlook for Heparin Anticoagulants

Out of Stock 12 Jan 2026
The 2023-2028 World Outlook for Heparin
96% match

The 2023-2028 World Outlook for Heparin

Out of Stock 08 Jan 2026
The 2023-2028 Outlook for Unfractionated Heparin in the United States
96% match

The 2023-2028 Outlook for Unfractionated Heparin in the United States

£520.00 07 Feb 2026
The 2023-2028 World Outlook for Unfractionated Heparin
96% match

The 2023-2028 World Outlook for Unfractionated Heparin

£795.00 13 Jan 2026
The 2023-2028 Outlook for Unfractionated Heparin in India
96% match

The 2023-2028 Outlook for Unfractionated Heparin in India

£515.00 31 Jan 2026
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in the United States

£595.00 17 Feb 2026
The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India
96% match

The 2016-2021 Outlook for Insulins and Anti-Diabetic Hormones and Synthetic Substitute Pharmaceuticals in India

£595.00 14 Feb 2026
The 2025-2030 World Outlook for Heparin Sodium
96% match

The 2025-2030 World Outlook for Heparin Sodium

Out of Stock 10 Dec 2025
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
96% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries
96% match

The 2025-2030 World Outlook for Next Generation Diabetes Therapy and Drug Deliveries

Out of Stock 28 Jan 2026
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in the United States
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in the United States

£595.00 10 Dec 2025
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Greater China
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Greater China

£595.00 10 Mar 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
96% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India

£495.00 07 Jan 2026
The 2026-2031 World Outlook for Smart Insulin Pens and Pumps
96% match

The 2026-2031 World Outlook for Smart Insulin Pens and Pumps

£885.00 06 Feb 2026
The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Japan
96% match

The 2016-2021 Outlook for Low Molecular Weight Heparin (LMWH) in Japan

£595.00 10 Mar 2026